Pharma & Biotech

DexCom finds itself at a pivotal moment as conflicting developments create uncertainty for investors. The continuous glucose monitoring leader faces...

Cellectar Biosciences finds itself navigating turbulent market conditions as its shares experience significant volatility. The biopharmaceutical company faces a complex...

Investors in Anavex Life Sciences are bracing for what could prove to be a defining moment for the biopharmaceutical company....

Viking Therapeutics has achieved a significant advancement in its obesity treatment program, completing patient enrollment for its pivotal Phase 3...

Pharmaceutical giant AbbVie is making decisive moves that signal a significant evolution in its corporate strategy. The company recently achieved...

With its shares hovering near historic lows, Veru Inc. is entering a pivotal period for its flagship drug candidate, Enobosarm....

The pharmaceutical giant from Leverkusen has achieved a significant regulatory victory during a period when the company continues to grapple...

Eli Lilly and Company is reinforcing its growth strategy beyond its highly successful weight loss and diabetes treatments through an...

UnitedHealth Group, the nation's largest provider of Medicare plans, is navigating a severe operational storm. The company is contending with...

Facing intense competitive pressure, Danish pharmaceutical giant Novo Nordisk is implementing a radical strategic shift. The company has announced dramatic...